M. Malissard

Comparison of Four Procedures for Measuring Elastase Production by Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients

J. Saulnier, J. Wallach, G. Döring, M. Malissard +2 more

1992European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies5 citations Open access

Semantic Scholar

M. Malissard

Most-cited papers

Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production.

Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS.

NanoLuc Luciferase – A Multifunctional Tool for High Throughput Antibody Screening

A novel role for junctional adhesion molecule‐A in tumor proliferation: Modulation by an anti‐JAM‐A monoclonal antibody

Expression of recombinant proteins in a lipid A mutant of Escherichia coli BL21 with a strongly reduced capacity to induce dendritic cell activation and maturation.

Exploring the Acceptor Substrate Recognition of the Human β-Galactoside α2,6-Sialyltransferase*

Immobilisation on polystyrene of diazirine derivatives of mono- and disaccharides: biological activities of modified surfaces.

Chemo-Enzymatic synthesis of the galili epitope Galα(1→3)Galβ(1→4)GlcNAc on a homogeneously soluble PEG polymer by a multi-Enzyme system

Improving solubility of catalytic domain of human beta-1,4-galactosyltransferase 1 through rationally designed amino acid replacements.

The yeast expression system for recombinant glycosyltransferases

Functional assignment of motifs conserved in β1,3‐glycosyltransferases

Efficacy of the Antibody–Drug Conjugate W0101 in Preclinical Models of IGF-1 Receptor Overexpressing Solid Tumors

The outer membrane protein X from Escherichia coli exhibits immune properties.

Middle level IM-MS and CIU experiments for improved therapeutic immunoglobulin subclass fingerprinting.

UDP-N-Acetyl-α-D-glucosamine as acceptor substrate of β-1,4-galactosyltransferase. Enzymatic synthesis of UDP-N-acetyllactosamine

Expression and purification of His-tagged beta-1,4-galactosyltransferase in yeast and in COS cells.

The stereochemistry of the reductive alkylation of anthracene

Complete enzymic synthesis of the mucin-type sialyl Lewis x epitope, involved in the interaction between PSGL-1 and P-selectin

Fed-batch production of a soluble β-1,4-galactosyltransferase with Saccharomyces cerevisiae

Exploring the acceptor substrate recognition of the human beta-galactoside alpha 2,6-sialyltransferase.

Abstract 3372: VISTA interaction with PSGL1, a likely VISTA receptor in tumors, is effectively disrupted by K0401-020 anti-VISTA antibody

Comparison of Four Procedures for Measuring Elastase Production by Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients

UDP-N-Acetyl-alpha-D-glucosamine as acceptor substrate of beta-1,4-galactosyltransferase. Enzymatic synthesis of UDP-N-acetyllactosamine.

Abstract 815: New approach for old target: W0101 antibody drug conjugate effectively inhibits tumor growth in preclinical models of IGF-1R overexpressing solid tumors

Chemo-enzymatic synthesis of the Galili epitope Gal(alpha)(1-->3)Galbeta(1-->4)GlcNAc on a homogeneously soluble PEG polymer by a multi-enzyme system.

Functional assignment of motifs conserved in beta 1,3-glycosyltransferases.

Middle-level IM-MS and CIU experiments for improved therapeutic immunoglobulin isotype fingerprinting

defensin production α TLRs and triggers Direct bacterial protein PAMP recognition by human NK cells involves

522 POSTER Discovery of the 6F4 anti-tumor antibody targeting the tight junction molecule JAM-A. 1. Target identification by proteomic approach